Dr. Sandy Feng is a transplant surgeon who performs liver, kidney and pancreas transplants.

In her research, Feng studies transplantation tolerance, a transplant recipient's ability to maintain normal organ function with minimal or no use of immunosuppressive drugs. With funding from the National Institutes of Health, she has led several multicenter clinical trials to study tolerance in both adult and pediatric liver transplant recipients.

Feng is a graduate of Harvard College, where she received the prestigious Marshall Scholarship. She completed a doctorate in molecular biology at the University of Cambridge and earned her medical degree at Stanford University School of Medicine. She completed a general surgery residency at Brigham and Women's Hospital, followed by a transplant fellowship at UCSF.

Feng has held leadership positions in prominent professional societies and with the United Network for Organ Sharing. She has organized several national conferences on issues critical to the transplantation community. She is the incoming editor-in-chief of the American Journal of Transplantation and serves on the New England Journal of Medicine's editorial board.

  • Education

    Stanford University School of Medicine, 1990

  • Residencies

    Brigham and Women's Hospital, General Surgery, 1995

  • Fellowship

    UCSF Medical Center, Transplant, 1998

  • Board Certifications

    Surgery, American Board of Surgery

  • Academic Title

    Professor

Kidney Transplant Center

400 Parnassus Ave., Seventh Floor
San Francisco, CA 94143

Liver Transplant Program

400 Parnassus Ave., Third Floor
San Francisco, CA 94143

Pancreas Transplant Services

400 Parnassus Ave., Seventh Floor
San Francisco, CA 94143

Decorative Caduceus

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biops...

Recruiting

Decorative Caduceus

A Cohort Study of Operationally Tolerant Allograft Recipients

Antirejection medicines, also known as immunosuppressive drugs, are prescribed to organ transplant recipients to prevent their bodies from rejecting the new organ. Some organ transplant recipients can stop taking ant...

Recruiting

Share